Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and design ...

Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...

The molecular glue wave that first began years ago is still swelling, with Eli Lilly earmarking approximately $1.65 billion ...

Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery, has entered a collaboration and license ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Ahead of whatever Jensen Huang & Co. announces, let's look at another highflying stock: Costco Wholesale (COST). Christopher Bloomstran, the president and chief investment officer St. Louis-based ...

Electrons possess both the electric property of charge and the magnetic property of spin simultaneously ... center has obtained a license for its cell proc... Eli Lilly mass-produces oral obesity ...

Yet the same day, CVS filed its annual report to shareholders with a new paragraph about “uncertainty” around changing health-care rules. The company warned that “efforts to reform federal government ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... a lot of people are going to say this is the end of Mag 7. And of NASDAQ. But people are discerning winners ...

Five researchers from Washington University in St. Louis have been named senior members of the National Academy of Inventors ...

Health Care led sector performance, driven by rebounds in Eli Lilly, UnitedHealth Group ... despite shakiness among some Mag 7 names. A pause in the dollar’s rally helped international equities ...